Growth opportunities in the PDX Model Market look promising over the next six years. This is mainly due to the expanding awareness among individuals, the capability to retain the tumor characteristics, and their power to forecast the effectiveness of therapies.
PDX Model Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)
Key Drivers
The augmented demand for customized medicines is a prominent driver stimulating the growth of the global PDX model market. This process is used to develop personalized medications to offer individuals treatment and care based upon personal and genetic differentiation. Also, they are made up of animal models, in which immunodeficient miniatures are transplanted with human tissues and to mark down the disease expressed. In addition, it is accompanied by curing them with drugs/gene therapies to find the best treatment, which helps to bring out the most appropriate medicines. The development of treatments for noxious diseases such as cancer has allured a significant market. Currently, cancer is a prime burden on healthcare facilities across the globe. According to GLOBOCAN, approximately 19.3 million cases and 10 million cancer deaths were registered in 2020. The In vitro and In vivo approaches are adapted to fight the augmenting cases of cancer and help to perform proper treatments to patients. A notable expansion in this regard is the introduction of PDX models, as they have immense potential to reflect the effectiveness of standard and new anti-cancer medicaments. Thereby, these models are increasingly implemented in preclinical studies.
However, the high cost associated with the creation and maintenance of these models and the requirement of costly drugs are the major factors hindering market growth. These experiments can cost thousands of dollars, even in the treatment of a single patient. Moreover, their applications in government-funded basic research can also be enormously expensive, which further curbs the PDX model market share.
Regional Drivers
Based on the regional coverage, North America is projected to witness a higher CAGR during the forecast period. This is mainly owing to a rise in endowment measures and creating consciousness among patients regarding personalized medicine. Patient-derived tumor xenografts are recognized as very pertinent cancer models. In accordance with the American Cancer Society estimates, in 2018, 1,735,350 novel incidences of cancer were witnessed by the US. Also, in 2018, the National Institute of Cancer extended the storage of these research models to store more of them. Hence, these are bolstering the market growth.
PDX Model Market’s leading Manufacturers:
- WuXi AppTec
- Charles River Laboratories
- Envigo
- Hera Biolabs
- JSR Corporation.
- THE JACKSON LABORATORY
- Oncodesign
- Pharmatest Services
- EPO Berlin-Buch GmbH
PDX Model Market Segmentation:
Segmentation by Type
- Mice Models
- Rat Models
Segmentation by Tumor type
- Gastrointestinal Tumor Models
- Gynecological Tumor Models
- Respiratory Tumor Models
- Urological Tumor Models
- Hematological Tumor Models
- Others
Segmentation by Application
- Preclinical Drug Development
- Biomarker Analysis
- Basic Cancer Research
Segmentation by End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutions
Segmentation by Region:
- North America
- United States of America
- Canada
- Asia Pacific
- China
- Japan
- India
- Rest of APAC
- Europe
- United Kingdom
- Germany
- France
- Spain
- Rest of Europe
- RoW
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Rest of the world (remaining countries of the LAMEA region)
About GMI Research
GMI Research is a market research and consulting company that offers business insights and market research reports for large and small & medium enterprises. Our detailed reports help the clients to make strategic business policies and achieve sustainable growth in the particular market domain. The company’s large team of seasoned analysts and industry experts with experience from different regions such as Asia-Pacific, Europe, North America, among others, provides a one-stop solution for the client. Our market research report has in-depth analysis, which includes refined forecasts, a bird’s eye view of the competitive landscape, key factors influencing the market growth, and various other market insights to aid companies in making strategic decisions. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping our clients to stay ahead of the curve.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com
